##gff-version 3
Q9UJY1	UniProtKB	Chain	1	196	.	.	.	ID=PRO_0000125945;Note=Heat shock protein beta-8	
Q9UJY1	UniProtKB	Domain	74	185	.	.	.	Note=SHSP;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00285	
Q9UJY1	UniProtKB	Region	176	196	.	.	.	Note=Disordered;Ontology_term=ECO:0000256;evidence=ECO:0000256|SAM:MobiDB-lite	
Q9UJY1	UniProtKB	Modified residue	24	24	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0007744,ECO:0007744,ECO:0007744;evidence=ECO:0007744|PubMed:18220336,ECO:0007744|PubMed:18669648,ECO:0007744|PubMed:23186163;Dbxref=PMID:18220336,PMID:18669648,PMID:23186163	
Q9UJY1	UniProtKB	Modified residue	57	57	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q9EPX0	
Q9UJY1	UniProtKB	Modified residue	63	63	.	.	.	Note=Phosphothreonine%3B by PKC%3B in vitro;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11816564;Dbxref=PMID:11816564	
Q9UJY1	UniProtKB	Modified residue	71	71	.	.	.	Note=Asymmetric dimethylarginine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q9JK92	
Q9UJY1	UniProtKB	Modified residue	78	78	.	.	.	Note=Asymmetric dimethylarginine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q9JK92	
Q9UJY1	UniProtKB	Natural variant	67	67	.	.	.	ID=VAR_042244;Note=In a glioblastoma multiforme sample%3B somatic mutation. G->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17344846;Dbxref=PMID:17344846	
Q9UJY1	UniProtKB	Natural variant	78	78	.	.	.	ID=VAR_042245;Note=R->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17344846;Dbxref=dbSNP:rs55826713,PMID:17344846	
Q9UJY1	UniProtKB	Natural variant	90	90	.	.	.	ID=VAR_078133;Note=In HMND2%3B no effect on cytoskeleton architecture%3B no effect on cytoplasmic location%3B no effect on interaction with BAG3. P->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28144995;Dbxref=dbSNP:rs1565927080,PMID:28144995	
Q9UJY1	UniProtKB	Natural variant	138	138	.	.	.	ID=VAR_078134;Note=In HMND2%3B no effect on cytoskeleton architecture%3B no effect on cytoplasmic location%3B no effect on interaction with BAG3. N->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28144995;Dbxref=dbSNP:rs1565929080,PMID:28144995	
Q9UJY1	UniProtKB	Natural variant	141	141	.	.	.	ID=VAR_018504;Note=In HMND2%3B strengthen interaction with HSPB1. K->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15122253;Dbxref=dbSNP:rs104894351,PMID:15122253	
Q9UJY1	UniProtKB	Natural variant	141	141	.	.	.	ID=VAR_078135;Note=In HMND2%3B no effect on cytoskeleton architecture%3B no effect on cytoplasmic location%3B increased interaction with BAG3. K->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28144995;Dbxref=dbSNP:rs1565929090,PMID:28144995	
Q9UJY1	UniProtKB	Natural variant	141	141	.	.	.	ID=VAR_018505;Note=In HMND2%3B strengthen interaction with HSPB1%3B no effect on cytoskeleton architecture%3B no effect on cytoplasmic location%3B increased interaction with BAG3. K->N;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15122253,ECO:0000269|PubMed:15565283,ECO:0000269|PubMed:28144995;Dbxref=dbSNP:rs104894345,PMID:15122253,PMID:15565283,PMID:28144995	
Q9UJY1	UniProtKB	Sequence conflict	51	51	.	.	.	Note=W->C;Ontology_term=ECO:0000305;evidence=ECO:0000305